Drug Shortage Report for SIMULECT

Last updated on 2024-07-10 History
Report ID 232638
Drug Identification Number 02242815
Brand name SIMULECT
Common or Proper name SIMULECT 20MG 1 X 1 VIALS
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) BASILIXIMAB
Strength(s) 20MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 X 1
ATC code L04AC
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-08-01
Actual start date
Estimated end date 2024-08-08
Actual end date
Shortage status Anticipated shortage
Updated date 2024-07-10
Company comments Product on allocation to minimize patient impact and avoid stock out at market level.
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2024-07-10 English Compare
v4 2024-07-10 French Compare
v3 2024-07-10 English Compare
v2 2024-07-10 French Compare
v1 2024-07-10 English Compare

Showing 1 to 5 of 5